Wall Street analysts’ outlook for Advent Technologies Holdings Inc. (ADN)

Advent Technologies Holdings Inc. (NASDAQ: ADN) stock jumped 3.23% on Wednesday to $1.92 against a previous-day closing price of $1.86. With 0.27 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.83 million shares. During the session, the Utilities – Renewable company that operates in wider Utilities sector, reached to the highest price of $1.9250 whereas the lowest price it dropped to was $1.8300. The 52-week range on ADN shows that it touched its highest point at $8.76 and its lowest point at $1.13 during that stretch. It currently has a 1-year price target of $9.35. Beta for the stock currently stands at -0.17.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ADN was up-trending over the past week, with a rise of 1.05%, but this was down by -12.73% over a month. Three-month performance dropped to -33.56% while six-month performance rose 39.13%. The stock lost -74.12% in the past year, while it has lost -72.61% so far this year. A look at the trailing 12-month EPS for ADN yields -0.69 with Next year EPS estimates of -0.67. For the next quarter, that number is -0.03. This implies an EPS growth rate of -561.80% for this year and 20.20% for next year.

Float and Shares Shorts:

At present, 51.72 million ADN shares are outstanding with a float of 25.07 million shares on hand for trading. On Oct 13, 2022, short shares totaled 1.7 million, which was 3.30% higher than short shares on Sep 14, 2022. In addition to Dr. Vassilios Gregoriou Ph.D. as the firm’s CEO & Chairman, Dr. Emory Sayre De Castro Ph.D. serves as its CTO & Exec. Director.

Institutional Ownership:

Through their ownership of 26.53% of ADN’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 29.63% of ADN, in contrast to 21.87% held by mutual funds. Shares owned by individuals account for 1.91%. As the largest shareholder in ADN with 10.58% of the stake, BNP Paribas Asset Management UK L holds 5,464,216 shares worth 5,464,216. A second-largest stockholder of ADN, The Vanguard Group, Inc., holds 1,267,268 shares, controlling over 2.45% of the firm’s shares. Penserra Capital Management LLC is the third largest shareholder in ADN, holding 744,572 shares or 1.44% stake. With a 14.07% stake in ADN, the BNP Paribas Funds – Energy Transi is the largest stakeholder. A total of 7,264,216 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 1.40% of ADN stock, is the second-largest Mutual Fund holder. It holds 724,921 shares valued at 1.64 million. Defiance Next Gen H2 ETF holds 1.38% of the stake in ADN, owning 713,366 shares worth 1.61 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ADN since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ADN analysts setting a high price target of $4.00 and a low target of $4.00, the average target price over the next 12 months is $4.00. Based on these targets, ADN could surge 108.33% to reach the target high and rise by 108.33% to reach the target low. Reaching the average price target will result in a growth of 108.33% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. ADN will report FY 2022 earnings on 03/27/2023. Analysts have provided yearly estimates in a range of -$0.69 being high and -$0.69 being low. For ADN, this leads to a yearly average estimate of -$0.69. The surprise factor in the prior quarter was $0.03. Based on analyst estimates, the high estimate for the next quarter is -$0.03 and the low estimate is -$0.03. The average estimate for the next quarter is thus -$0.03.

Summary of Insider Activity:

Insiders traded ADN stock several times over the past three months with 0 Buys and 2 Sells. In these transactions, 0 shares were bought while 30,969 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has risen to 5 over the past year. The total number of shares bought during that period was 368,548 while 191,184 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam